metallodrugs

Term used to define a pharmaceutical, having a activity center containing a metal. Platinum (cisplatin, carboplatin) and gold (Auranofin) compounds are well-known in cancer therapy whereas some other gold compounds (aurithiomalate, aurothioglucose) are important antiarthritic drugs. A wide range of Tc compounds (e.g. Tc-labelled antibodies, Tc-mercaptoacetyl glycine complex) are used for diagnostic imaging of renal, cardiac and cerebral functions and of various forms of cancer. Gadolinium (III) polyaminopolycarboxylic crown complexes are widely used as contrast agents in magnetic resonance imaging.



The term "metallodrugs" was found in the following pages:

What's new ? | EVISA's News
Solid-phase extraction in speciation analysis | EVISA's News
Link database: USA: Ohio State University: Cowan Group
Tracing Gadolinium-based Contrast Agents from Wastewater, via Surface Water to Drinking Water | EVISA's News
EVISA's activities during the year 2012 | EVISA's News
Link database: Italy: Interdepartmental Research Center “Role of Metal Ions in Biomedical Sciences - BIOMÉTION”
Side effects of cisplatin chemotherpy: Platinum speciation matters | EVISA's News
Impressions from the 5th Metallomics Symposium | EVISA's News
The behavior of Gd-based contrast agents during wastewater treatment | EVISA's News
Speciation analysis for cancer diagnosis | EVISA's News
Themed Issue "Metallomics 2011" now available | EVISA's News
All about Pharmacy and Pharmaceutical Sciences | EVISA's News
FDA investigating risk of gadolinium contrast agent brain deposits | EVISA's News
EMA Issues Final Opinion Limiting Gadolinium Contrast Agents in Body Scans | EVISA's News
Chemical speciation as a discipline in Analytical Chemistry – Definitions
New Studies Question Safety of MRI Contrast Agents | EVISA's News
FDA identifies no harmful effects to date with brain retention of gadolinium-based contrast agents for MRIs | EVISA's News
Dartmouth researchers find that arsenic triggers unique mechanism in rare leukemia | EVISA's News
Books and Special Issues on Elemental Speciation (published since 2016) | EVISA's News
Copper molecule shows promise in fighting against cancer | EVISA's News